3.0659

6.45% 0.1859

Pre-market: 3.13 0.0641 +2.09%

Cardio Diagnostics Holdings Inc (CDIO)

Overview News Price History Financials Discussions Forecast

Cardio Diagnostics Holdings Inc stock is traded at $3.0659, with a volume of 5,490. It is up +6.45% in the last 24 hours and down -15.31% over the past month. Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Previous Close:

$2.88

Open:

$2.9245

24h Volume:

5,490

Relative Volume:

0.16

Market Cap:

$5.60M

Revenue:

Net Income/Loss:

$-9.37M

P/E Ratio:

-3.3695

EPS:

-0.9099

Net Cash Flow:

$-7.34M

1W Performance:

+4.28%

1M Performance:

-15.31%

6M Performance:

-38.56%

1Y Performance:

-65.66%

1-Day Range:

$2.905

$3.10

1-Week Range:

$2.84

$3.13

52-Week Range:

$2.4237

$53.10

Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile

Name

Cardio Diagnostics Holdings Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

855-226-9991

Address

311 W. SUPERIOR STREET, CHICAGO

Employee

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

CDIO's Discussions on Twitter

Compare CDIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDIO Cardio Diagnostics Holdings Inc	3.0659	5.26M	0	-9.37M	-7.34M	-0.9099
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News

02:38 AM

Is Cardio Diagnostics Holdings Inc. stock a contrarian buyAnalyst Upgrade & High Accuracy Swing Trade Signals - Newser

02:38 AM

Dec 03, 2025

Cardio Diagnostics Holdings IncCMS sets final payment rate of $854 for cardiovascular tests - MarketScreener

Dec 03, 2025

CMS sets final payment rate of $854 for Cardio Diagnostics tests - Investing.com

Dec 03, 2025

Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Bakersfield.com

Dec 03, 2025

Cardio Diagnostics Holdings Announces Final Gapfill Payment Rates For Epi+Gen CHD And PrecisionCHD Tests - marketscreener.com

Dec 03, 2025

What risks investors should watch in Cardio Diagnostics Holdings Inc. Equity Warrant stock2025 Trade Ideas & Technical Confirmation Trade Alerts - Newser

Dec 03, 2025

Dec 01, 2025

Cardio Diagnostics Hldgs (CDIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 28, 2025

US Market Recap: How strong is Cardio Diagnostics Holdings Inc. stock balance sheetTrade Performance Summary & Short-Term Trading Opportunity Alerts - moha.gov.vn

Nov 28, 2025

Nov 21, 2025